GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas

Since the prognosis for children with high-risk osteosarcoma (OS) remains suboptimal despite intensive multi-modality therapies, there is a clear and urgent need for the development of targeted therapeutics against these refractory malignancies. Chimeric antigen receptor (CAR) modified T cells can m...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Cancer Res
Asıl Yazarlar: Chulanetra, Monrat, Morchang, Atthapan, Sayour, Elias, Eldjerou, Lamis, Milner, Rowan, Lagmay, Joanne, Cascio, Matt, Stover, Brian, Slayton, William, Chaicumpa, Wanpen, Yenchitsomanus, Pa-Thai, Chang, Lung-Ji
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061749/
https://ncbi.nlm.nih.gov/pubmed/32195035
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller